Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
168, С. 115721 - 115721
Опубликована: Окт. 16, 2023
Intersected
pathways
between
circadian
timing
system
(CTS),
sleep
regulatory
centers
(SLEEP=Backspace)
and
endocannabinoid
(CB)
towards
cardiometabolic
dysfunctions
disorders
(cardiometabolic
risk).
The
stress
role
is
affected,
both
by
peripheral
(oxidative
signaling
proinflammatory
activation)
central
(autonomic
reaction)
factors
that
are
eventually
related
with
distinct
mediators
as
cyclooxigenase,
nitric
oxide
orexin,
others.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
168, С. 115805 - 115805
Опубликована: Окт. 31, 2023
Cannabidiol
(CBD),
a
cannabinoid
that
does
not
create
psychoactive
activities,
has
been
identified
as
having
multitude
of
therapeutic
benefits.
This
study
delves
into
the
chemical
properties,
pharmacokinetics,
safety
and
toxicity,
pharmacological
effects,
most
importantly,
association
between
potential
CBD
nuclear
factor
erythroid
2-related
2
(Nrf2)
signaling
pathway.
The
relationship
Nrf2
is
closely
linked
to
certain
proteins
are
associated
with
cardiovascular
dysfunctions,
cancers,
neurodegenerative
conditions.
Specifically,
connected
initiation
progression
diverse
health
issues,
including
nephrotoxicity,
bladder-related
diseases,
oral
mucositis,
obesity,
myocardial
injury
angiogenesis,
skin-related
inflammations,
psychotic
disorders,
neuropathic
pain,
Huntington's
disease,
Alzheimer's
Parkinson's
neuroinflammation,
Amyotrophic
Lateral
Sclerosis,
Multiple
Sclerosis.
zone
great
interest
in
medical
field,
it
significantly
impact
treatment
prevention
wide-ranging
Additional
investigation
necessary
entirely
apprehend
mechanisms
underlying
this
crucial
interplay
develop
effective
interventions.
Pharmaceutics,
Год журнала:
2023,
Номер
15(9), С. 2280 - 2280
Опубликована: Сен. 4, 2023
Cannabinoids:
cannabidiol
(CBD),
cannabidiolic
acid
(CBDA),
and
cannabichromene
(CBC)
are
lipophilic
compounds
with
limited
water
solubility,
resulting
in
challenges
related
to
their
bioavailability
therapeutic
efficacy
upon
oral
administration.
To
overcome
these
limitations,
we
developed
co-dispersion
cannabinoid
delivery
systems
the
biopolymer
polyvinyl
caprolactam-polyvinyl
acetate-polyethylene
glycol
(Soluplus)
magnesium
aluminometasilicate
(Neusilin
US2)
improve
solubility
permeability.
Recognizing
potential
benefits
arising
from
entourage
effect,
decided
work
an
extract
instead
of
isolated
cannabinoids.
Cannabis
sativa
inflorescences
(Henola
variety)
a
confirming
neuroprotective
activity
were
subjected
dynamic
supercritical
CO2
(scCO2)
extraction
next
they
combined
carriers
(1:1
mass
ratio)
prepare
(HiE).
In
vitro
dissolution
studies
conducted
evaluate
CBD,
CBDA,
CBC
various
media
(pH
1.2,
6.8,
fasted,
fed
state
simulated
intestinal
fluid).
The
HiE-Soluplus
consistently
demonstrated
highest
rate
Additionally,
exhibited
permeability
coefficients
for
cannabinoids
gastrointestinal
tract
conditions
than
it
was
during
using
model
PAMPA
GIT.
All
three
promising
blood-brain
barrier
(BBB)
(Papp
higher
4.0
×
10−6
cm/s),
suggesting
effectively
cross
into
central
nervous
system.
improved
system
hold
promise
enhancement
bioavailability.
Molecules,
Год журнала:
2024,
Номер
29(22), С. 5471 - 5471
Опубликована: Ноя. 20, 2024
Cannabigerol
(CBG),
a
non-psychoactive
cannabinoid
found
in
cannabis,
has
emerged
as
promising
therapeutic
agent
with
diverse
range
of
potential
applications.
Unlike
its
well-known
counterpart
tetrahydrocannabinol
(THC),
CBG
does
not
induce
intoxication,
making
it
an
attractive
option
the
clinic.
Recent
research
shed
light
on
CBG's
intriguing
molecular
mechanisms,
highlighting
to
modulate
multiple
physiological
processes.
This
review
delves
into
current
understanding
interactions
and
explores
power
alleviate
various
conditions,
including
cancer,
metabolic,
pain,
inflammatory
disorders,
amongst
others.
We
discuss
how
interacts
endocannabinoid
system
other
key
signaling
pathways,
such
CB1,
CB2,
TPR
channels,
α2-adrenoceptor,
potentially
influencing
inflammation,
neurodegeneration,
ailments.
Additionally,
we
highlight
ongoing
efforts
aimed
at
elucidating
full
spectrum
safety
profile
clinical
settings.
Through
this
comprehensive
analysis,
aim
provide
deeper
role
promoting
human
health
pave
way
for
future
endeavors.
Antioxidants,
Год журнала:
2024,
Номер
13(11), С. 1284 - 1284
Опубликована: Окт. 24, 2024
The
endoplasmic
reticulum
(ER)
is
the
organelle
mainly
involved
in
maintaining
cellular
homeostasis
and
driving
correct
protein
folding.
ER-dependent
defects
or
dysfunctions
are
associated
with
genesis/progression
of
several
pathological
conditions,
including
cancer,
inflammation,
neurodegenerative
disorders,
that
directly
indirectly
correlated
to
a
wide
set
events
collectively
named
under
term
"ER
stress".
Despite
recent
increase
interest
concerning
ER
activity,
further
research
studies
needed
highlight
all
mechanisms
responsible
for
failure.
In
this
field,
discoveries
paved
way
comprehension
strong
interaction
between
stress
development
endocannabinoid
system.
activity
system
mediated
by
activation
cannabinoid
receptors
(CB),
G
protein-coupled
induce
decrease
cAMP
levels,
downstream
anti-inflammatory
effects.
CB
drives,
most
cases,
recovery
through
regulation
hallmarks
PERK,
ATF6,
IRE1.
review,
we
focus
on
role
modulating
stress,
particular
attention
processes
leading
UPR
oxidative
response
extinguishment,
underlying
natural
cannabinoids'
modulation
complex
machine.
The
dynamic
interaction
between
carbon
nanodots
(CNDs)
and
cannabidiol
(CBD)
has
captured
significant
attention
as
an
innovative
avenue
for
redefining
drug
delivery
amplifying
therapeutic
effectiveness.
This
in-depth
review
delves
into
the
intricate
synergy
these
two
elements,
unveiling
their
profound
potential
in
medicine.
Commencing
with
examination
of
unique
characteristics
CNDs
techniques
governing
synthesis,
we
discuss
versatility
carriers,
highlighting
invaluable
role
advancing
CBD
delivery.
Cannabidiol,
a
non-psychoactive
compound
sourced
from
cannabis,
emerged
focal
point
its
diverse
attributes.
Nevertheless,
limitations
posed
by
restricted
bioavailability
susceptibility
to
degradation
pose
substantial
hindrances
realizing
full
potential.
Here,
elucidate
how
amalgamation
transcends
challenges.
We
delve
mechanisms
that
underlie
this
synergy,
such
augmentation
solubility
safeguarding
against
premature
breakdown,
providing
analysis.
will
also
journey
you
through
comprehensive
exploration
loading
onto
CNDs,
dissecting
realms
physical
encapsulation,
covalent
bonding,
adsorption
processes.
In
summation,
combination
presents
extraordinary
opportunity
elevate
outcomes.
synergetic
paradigm
masterfully
tackles
pivotal
challenges
delivery,
thereby
paving
path
pioneering
medical
solutions.
Journal of Advances in Medicine and Medical Research,
Год журнала:
2023,
Номер
35(24), С. 14 - 22
Опубликована: Дек. 13, 2023
Aim:
Assess
alterations
in
circulating
endocannabinoid
levels
and
their
potential
correlation
with
the
progression
of
chronic
kidney
disease.
Additionally,
study
aims
to
consider
implications
for
clinical
use
these
compounds.
Study
Design:
Descriptive,
qualitative,
retrospective
observational
approach,
utilizing
a
methodological
framework
grounded
bibliographic
examination
publications
featured
indexed
journals.
Methodology:
An
exploration
was
conducted
on
academic
search
platform
PubMed,
using
terms
"endocannabinoid
system"
"kidney
disease,"
chronological
filter
spanning
last
10
years.
This
yielded
60
articles,
which
then
underwent
screening
sorting
process
platform's
tools
categorize
documents
based
thematic
relevance.
Results:
The
exhaustive
cannabinoid
signaling
disease
unveils
nuanced
intricate
landscape
where
distinctive
functions
CB1
CB2
receptors
become
apparent.
manipulation
system
arises
as
potentially
efficacious
therapeutic
approach
mitigating
injury,
substantiated
by
evidence
highlighting
its
pivotal
role
homeostasis
normal
function.
Nevertheless,
interplays
renal
physiology
demand
circumspect
methodology
formulation
interventions,
considering
varied
effects
observed
different
contexts
function.
Conclusion:
interaction
between
function
presents
promising
avenue,
offering
valuable
insights
development
innovative
approaches
treatment
diseases.
BioTech,
Год журнала:
2024,
Номер
13(4), С. 53 - 53
Опубликована: Дек. 2, 2024
Cannabis
sativa
plants
have
been
widely
investigated
for
their
specific
compounds
with
medicinal
properties.
These
bioactive
exert
preventive
and
curative
effects
on
non-communicable
infectious
diseases.
However,
C.
extracts
barely
investigated,
although
they
constitute
an
affordable
option
to
treat
human
Nonetheless,
antioxidant,
antimicrobial,
immunogenicity
associated
extracts.
Furthermore,
innovative
extraction
methods
in
combination
nanoformulations
proposed
increase
desirable
compounds’
availability,
distribution,
conservation,
which
can
be
aided
by
modern
computational
tools
a
transdisciplinary
approach.
This
review
aims
describe
available
nanoformulation
sativa,
as
well
its
known
immunogenic
activities.
Critical
points
the
use
of
are
identified
some
prospects
envisaged.
Background
The
use
of
cannabis
has
been
associated
with
an
array
multi-systemic
physiological
effects.
However,
the
medical
literature
on
potential
role
cannabinoids
in
management
and
outcomes
thyrotoxicosis
remains
scarce.
We
studied
association
between
orbitopathy,
dermopathy,
length
hospital
stay
for
admissions.
Methods
A
thorough
analysis
was
conducted
adult
hospitalizations
2020
a
primary
discharge
diagnosis
thyrotoxicosis,
using
data
from
Nationwide
Inpatient
Sample
(NIS).
To
ensure
completeness
consistency,
missing
or
incomplete
information,
as
well
those
involving
patients
under
18
years
age,
were
excluded
study.
remaining
study
sample
categorized
into
two
groups
based
presence
absence
use,
determined
by
ICD-10-CM/PCS
codes.
Subtypes
confounding
factors
identified
previous
defined
validated
evaluated
multivariate
regression
analysis.
focus
thyroid
while
dermopathy
average
considered
secondary
outcomes.
Results
total
7,210
included
Among
them,
404
(5.6%)
6,806
(94.4%)
non-users
serving
controls.
Cannabis
users
predominantly
female
(227,
56.3%),
which
similar
to
control
group
(5,263,
73%),
they
primarily
Black
descent.
Notably,
cohort
significantly
younger
than
(37.7
±
1.3
vs.
63.6
0.3).
Upon
conducting
analysis,
it
found
that
linked
significant
increase
odds
orbitopathy
among
(AOR:
2.36;
95%
CI:
1.12-4.94;
P
=
0.02).
Additionally,
history
tobacco
smoking
also
correlated
higher
1.21;
0.76-1.93;
p
0.04).
no
observed
0.88;
0.51-1.54;
0.65)
(IRR:
0.44;
0.58-1.46;
0.40).
Conclusion
increased
thyrotoxicosis.
be
augmented
orbitopathy.